14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine
C64H52N2O4 — CID 134561116
Data last refreshed: (MolForge compound catalog, from PubChem)
About 14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine
14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine (PubChem CID 134561116) has the molecular formula C64H52N2O4 and a molecular weight of 913.13 g/mol. Its IUPAC name is 14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine.
Molecular Properties
| Compound Name | 14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine |
|---|---|
| PubChem CID | 134561116 |
| Molecular Formula | C64H52N2O4 |
| Molecular Weight | 913.13 g/mol |
| Exact Mass | 912.39 |
| IUPAC Name | 14-N,31-N-bis(4-tert-butylphenyl)-14-N,31-N-bis(2-methylphenyl)-12,17,29,34-tetraoxanonacyclo[18.14.0.03,18.04,16.05,13.06,11.021,33.022,30.023,28]tetratriaconta-1(20),2,4(16),5(13),6,8,10,14,18,21(33),22(30),23,25,27,31-pentadecaene-14,31-diamine |
| SMILES | Cc1ccccc1N(c1ccc(C(C)(C)C)cc1)c1cc2oc3cc4c(cc3c2c2c1oc1ccccc12)oc1cc(N(c2ccc(C(C)(C)C)cc2)c2ccccc2C)c2oc3ccccc3c2c14 |
| InChI | InChI=1S/C64H52N2O4/c1-37-17-9-13-21-47(37)65(41-29-25-39(26-30-41)63(3,4)5)49-35-55-57(59-43-19-11-15-23-51(43)69-61(49)59)45-33-54-46(34-53(45)67-55)58-56(68-54)36-50(62-60(58)44-20-12-16-24-52(44)70-62)66(48-22-14-10-18-38(48)2)42-31-27-40(28-32-42)64(6,7)8/h9-36H,1-8H3 |
| InChIKey | HYQKDFZOMAVZKS-UHFFFAOYSA-N |
| XLogP | 19.44 |
| TPSA | 59.04 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 70 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 913.13 |
| LogP ≤ 5 | 19.44 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134561116 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.